The FDA has approved elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with estrogen receptor–positive (ER+), HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least 1 line of endocrine therapy.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.
M3P will be a financial lifeline for seniors while lowering certain pharmacy costs, but more education and tools are needed to make it successful with pharmacies and their customers.
Patients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.
Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.
The Act is part of a federal attempt to streamline the research process for medical marijuana and provide more attainable security requirements
Many pharmacy professionals feel discouraged, underutilized, and undervalued, but the support staff often saves the day.
How pharmacy teams can remove cost barriers to cardiac care.
Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Data show these cases pose some of the most significant threats to patients and health systems.
With the organism’s potential to cause severe symptoms, severe disease, and possible death, it is essential to care for infected individuals promptly and safely.
One could also argue that the Great Resignation is an era for a great realignment. During lockdown, many individuals took the time to realign their priorities.
The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment for pharmacies and their involvement in the cannabis market.
The expansion of roles is a testament to technicians' indispensable worth in safeguarding medication safety and promoting the profession.
AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.
Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.
Product verification allows technicians to practice at the top of their license and frees pharmacists to interact with patients.
Real-world metrics demonstrate that using health-system specialty pharmacies (HSSPs) means everyone wins: health systems, clinicians, and patients.
The therapy offers new hope in solid tumor treatment with fewer adverse effects.
Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
The number of medical visits carried out via telehealth grew from 840,000 in 2019 to 52.7 million in 2020.
Pharmacists play an important role in providing education and support with adherence to PrEP in populations with a high risk for HIV infection.
Advances, challenges, and promising innovations emerge.
Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.